All material subject to strictly enforced copyright laws. © 2022 Managing IP is part of the Euromoney Institutional Investor PLC group.

Podcast: Novartis, ML&P and ex-GSK counsel on COVID pools

re-podcast-logo.png

Guests debate how patent pools could be used to ensure global access to COVID treatments and vaccines, as well as how the pandemic has changed the IP system


To listen to the podcast, which is nearly 50 minutes, click the link below.

For the first Managing IP podcast, Charlotte Kilpatrick and IP experts discussed the ramifications of the COVID-19 crisis on the patent system and how the virus could change how pharma innovators conduct research and collaborate.

A highlight was a debate on the role patent pools could play to accelerate research for COVID treatments and vaccines. Ellen 't Hoen, director of the Medicines Law and Policy research institute in the Netherlands, stressed the importance for pharma innovators to use patent pools as a way to ensure global access to the vaccines once they become available. She pointed to the example of the Medicines Patent Pool, which negotiates licences for HIV and tuberculosis medications with generics companies, which can produce treatments at an affordable cost for developing countries.

David Rosenberg, former vice president of IP policy at GSK, agreed that a patent pool could be one solution among many to ensure access, but added he doesn’t believe a pool will be the ideal way for companies to conduct business and that innovators are more confident to negotiate with generics companies they already know. 

Corey Salsberg, vice president and global head of IP affairs at Novartis in Washington DC, noted that because tackling COVID-19 could involve multiple vaccines as well as treatments for those with advanced symptoms, a single patent pool might not be the best solution to ensure access.

Enjoy the podcast. 








more from across site and ros bottom lb

More from across our site

Federal Circuit okays USPTO director review policies; Red Bull sees off Monster TM appeal; Cisco victorious in Massachusetts court; Vimeo to pay $9m to Italian broadcaster; Mars wins TM suit over cannabis edibles; US gov sides with photographer in Warhol SCOTUS suit; Singers protest Mariah Carey’s ‘Queen of Christmas’ TM filing
In Europe’s patent litigation capital, German firms are in a race for work at the new Unified Patent Court
SMEs can be a joy to work with, but missed deadlines and poor communication can be immensely stressful, attorneys tell Managing IP
The England and Wales High Court ruled that takedown requests can be considered an ‘unjustified threat’, but lawyers say room for manoeuvre remains
Automated letters are giving Canadian TM filers a means to reduce their wait times, but navigating them can be complicated
Lawyers at IBM, Siemens and other firms reveal how they avoid disagreements over what occurred during interviews
This year’s firm rankings cover several practice areas, including copyright, intellectual property transactions, patent litigation, and trademark protection
Sources say the ruling may indicate KIPO’s shifting attitude towards protecting artists’ rights, but appellate bodies are likely to side with agencies
Sources say that the exam format should be revamped to test aptitude rather than rote learning and increase accessibility
The Italian firm that built the UPC case management system plans to launch a full training course in October
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree